ABPI announces new president
This article was originally published in Scrip
The Association of the British Pharmaceutical Industry (ABPI) has appointed John Kearney president of the association. He will take up office on 24 April 2015. Mr Kearney replaces Jonathan Emms who is stepping down as president following a promotion within Pfizer which sees him relocating to the US.
You may also be interested in...
A rush in the 2010s of high-tech and digital companies focused on women’s health and wellbeing are maturing, adding weight to the more traditional women's health market that has struggled to get attention from investors in the past.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
A selection of articles you might have missed from September 2020, including exclusive interviews with industry leaders and a review of value-based contract approaches in the US.